UCLA researchers found that boosting p53 protein with navtemadlin helped T cells fight melanoma cancer cells longer, but dosing challenges remain.

When you're going through cancer treatment or recovering afterwards, rest might seem like the best medicine. But research shows that exercise can also play an important role in managing cancer ...

Dr. Elizabeth Comen explains why managing side effects, speaking up about challenges and protecting your quality of life are ...

By Dennis Thompson HealthDay ReporterMONDAY, Oct. 26, 2026 (HealthDay News) — Starting survivorship care for patients with ...

The findings build on related research from the Johns Hopkins team published earlier this year. In that study, investigators examined the atomic structure of DCTPP1 and identified several classes of ...

Eleventh annual fundraising effort brings Lendmark’s cumulative total to more than $12.4 million raised for pediatric cancer research and family supportLAWRENCEVILLE, Ga., Nov. 02, 2026 (GLOBE ...

A headline about a "breakthrough cancer vaccine" is bound to raise a big question: Can it actually cure cancer? That's what many patients are wondering after Moderna and Merck announced promising ...

Rutika Mehta, MD, MPH, discusses perioperative durvalumab plus FLOT and first-line options for patients with low or negative ...

Learn how colon cancer treatment varies by stage, from surgery for early disease to chemotherapy, targeted therapy, and ...

The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...